MAI Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.3K | Buy |
135
+70
| +108% | +$7.43K | ﹤0.01% | 2374 |
|
|
2025
Q1 | $8.07K | Sell |
65
-197
| -75% | -$24.5K | ﹤0.01% | 2406 |
|
|
2024
Q4 | $32.3K | Buy |
+262
| New | +$32.3K | ﹤0.01% | 1879 |
|
|
2020
Q2 | – | Sell |
-4,998
| Closed | -$499K | – | 525 |
|
|
2020
Q1 | $499K | Buy |
4,998
+275
| +6% | +$27.5K | 0.02% | 341 |
|
|
2019
Q4 | $705K | Sell |
4,723
-61
| -1% | -$9.11K | 0.02% | 338 |
|
|
2019
Q3 | $613K | Buy |
4,784
+420
| +10% | +$53.8K | 0.03% | 314 |
|
|
2019
Q2 | $622K | Buy |
4,364
+96
| +2% | +$13.7K | 0.03% | 308 |
|
|
2019
Q1 | $610K | Sell |
4,268
-300
| -7% | -$42.9K | 0.03% | 270 |
|
|
2018
Q4 | $566K | Sell |
4,568
-64
| -1% | -$7.93K | 0.03% | 277 |
|
|
2018
Q3 | $779K | Sell |
4,632
-241
| -5% | -$40.5K | 0.04% | 261 |
|
|
2018
Q2 | $840K | Buy |
+4,873
| New | +$840K | 0.05% | 235 |
|